
Sign up to save your podcasts
Or


In the first of a two part-series, Anthony and Bernie dive into the data surrounding maintenance therapies in AML. This episode focuses on maintenance therapy for patients ineligible for transplant, with a focus on oral azacitidine and the controversial QUAZAR study.
Key References:
By Bernard Marini, Anthony Perissinotti, et al.4.5
3030 ratings
In the first of a two part-series, Anthony and Bernie dive into the data surrounding maintenance therapies in AML. This episode focuses on maintenance therapy for patients ineligible for transplant, with a focus on oral azacitidine and the controversial QUAZAR study.
Key References:

38,430 Listeners

26,012 Listeners

87,868 Listeners

113,121 Listeners

56,944 Listeners

187 Listeners

10,331 Listeners

7,244 Listeners

53 Listeners

8 Listeners

16,525 Listeners

11,013 Listeners

51 Listeners

195 Listeners

747 Listeners